Used as a prodrug in antibacterial formulations, particularly effective against resistant Gram-positive and Gram-negative pathogens. The compound enhances oral bioavailability of the active β-lactam metabolite by improving intestinal absorption. Once absorbed, it is hydrolyzed to release the active carba-penem, which inhibits bacterial cell wall synthesis. Its structure provides stability against many β-lactamases, making it valuable in treating infections where standard antibiotics fail. Commonly indicated for respiratory, urinary tract, and skin infections caused by multidrug-resistant organisms.